483 results found

Insights, the latest trends of online shopping and tax and consumer preferences in China's food & beverage market.

Since 2013, the Drug Evaluation Center of the State Medical Products Administration (hereinafter referred to as CDE) has released the annual drug review report of the previous year every year...

China has been endeavoring to make comprehensive and fundamental regulatory reform of drug and medical device, in particular in the drug and medical device registration system.

Hainan Boao Lecheng International Medical Tourism Pilot Zone (the "Pilot Zone") was established with the approval of the State Council in 2013 and granted many preferential policies...

만약 발명이 기술적 편견을 극복하고 사람들이 기술적 편견으로 인해 포기하는 기술적 수단을 채택하여 기술적 문제를 해결했다면 이런 발명은 두드&#

疫情下药品进口法律法规简析

The opportunity to decide writing this article is a startling photo that pop into my eyes when searching the meaning of the word "thalidomide" on the Internet.

China has emerged as a global pharmaceutical innovation powerhouse, leveraging its scientific expertise, AI capabilities, and streamlined regulatory environment to accelerate drug development.

China's pharmaceutical industry is witnessing a notable surge in "pipeline spin-off projects", a model commonly referred to as the "Spin-off-NewCo" or "SON"...

The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) recently released the Acceptance Review Guideline on Biological Products Changes (for Trial Implementation).

China's regulators intensified anti-corruption enforcement in the life sciences sector during the first half of 2026, introducing stricter oversight of medical data security, sales representatives, and public procurement processes. New administrative measures and judicial interpretations have lowered thresholds for criminal liability while expanding corporate accountability for employee misconduct.

On 23 July 2025, China's State Administration for Market Regulation (SAMR) issued a prohibition decision against Wuhan Yongtong Pharmaceutical's (YT Pharma) acquisition of Shandong...

Recently, renowned intellectual property magazine Asia IP announced the result of its 2021 Patent Survey, which has been published in the September issue of Asia IP.

It was a strange coincident that when I visited the CNIPA last week at the CNIPA/American Bar Association Liaison Council China delegation 2023.

China is becoming an increasing focus for transactions in the pharmaceuticals sector with its growing investment into research and development, government support and a steady...

"老药新用"是指发现了某已知药品固有的、但迄今为止未被认识的新的性质或功能，从而将该药品用于新的领域或目的的发明。简单来说，在老&#

The 24th session of the Standing Committee of the 13th National People's Congress deliberated on the "Anti-food- Waste Law of the People's Republic of China (Draft)", which has been published for public comments.